Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto-Culver “right-sizes”

This article was originally published in The Rose Sheet

Executive Summary

Two marketing units will be combined into one as part of a company-wide reorganization following the firm's separation from Sally Beauty, it announces Dec. 1. In addition, certain international services will either be outsourced or combined into regional offices. The company also plans to reduce its workforce of 3,800 employees by approximately 90 and close its Dallas, Texas manufacturing facility by the end of 2007. The reorganization represents a "right-sizing" of the company, taking into consideration "services we were maintaining in support of Sally and corporate activities that could be scaled back to match the needs of a smaller company," according to Jim Marino, president and CEO. The firm expects to incur restructuring charges of approximately $13 mil. and $3 mil. in Q1 and Q2 of 2007, respectively. The reorganization and all financial charges related to it are expected to be "substantially completed" by the end of Q2 2007. Alberto-Culver broke from Sally Beauty in November (1"The Rose Sheet" Nov. 27, 2006, In Brief)...

You may also be interested in...



Alberto-Culver Maintains Aggressive Marketing Strategy; Q3 Sales Up 9.2%

Alberto-Culver cites Nexxus and TRESemme as outstanding contributors to its third-quarter growth; the company booked $385.5 million for the quarter, up 9.2 percent versus the prior-year period

Alberto-Culver Q1

Firm reports results of its first quarter (ended Dec. 31) as an independent company Jan. 25, crediting 12.6% increase in sales to $351.1 mil. to strong growth in Nexxus and TRESemme. Gross profit grew 12.3% to $180.9 mil., while earnings were "essentially breakeven" after restructuring costs, firm says. The company increased its ad spend 20.9% to $61 mil. as part of an "ongoing effort to support and further expand our brands," president and CEO V. James Marino said. "This quarter marks a new beginning for Alberto-Culver and its shareholders, and we are focused on our efforts to drive results and create value over the long term," he remarked. Brand announced a "right-sizing" plan in December (1"The Rose Sheet" Dec. 4, 2006, In Brief)...

Alberto-Culver appointments

Company appoints three new directors to its board following its November break from Sally Beauty, Alberto-Culver states Dec. 7. Kay Napier, Thomas Dattilo and George Fotiades will join the board along with President and CEO Jim Marino, firm says. The three appointees will replace A.G. Atwater, William Wirtz and Howard Bernick, who retired from the board following completion of the separation transaction, and John Miller, who joined the new board of Sally Beauty Holdings. Alberto-Culver completed its separation from Sally Beauty Nov. 16; the entities are now two separate, publicly traded companies. In December, the firm announced a reorganization plan meant to "right-size" the company (1"The Rose Sheet" Dec. 4, 2006, In Brief)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel